Cited by 337Drug Transport and Resistance MechanismsPharmacogenetics and Drug MetabolismProtein Interaction Studies and Fluorescence Analysis

The DOI matches its Crossref record; 199 of the 199 references it cites were found in a registry or an index.

EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS

Shitara, Yoshihisa, Sato, Hitoshi, Sugiyama, Yuichi·2005·Annual Review of Pharmacology and Toxicology

DOI 10.1146/annurev.pharmtox.44.101802.121444

Open this paper in CoChat — free account

Abstract

Recent studies have revealed the import role played by transporters in the renal and hepatobiliary excretion of many drugs. These transporters exhibit a broad substrate specificity with a degree of overlap, suggesting the possibility of transporter-mediated drug-drug interactions with other substrates. This review is an overview of the roles of transporters and the possibility of transporter-mediated drug-drug interactions. Among the large number of transporters, we compare the Ki values of inhibitors for organic anion transporting polypeptides (OATPs) and organic anion transporters (OATs) and their therapeutic unbound concentrations. Among them, cephalosporins and probenecid have the potential to produce clinically relevant OAT-mediated drug-drug interactions, whereas cyclosporin A and rifampicin may trigger OATP-mediated ones. These drugs have been reported to cause drug-drug interactions in vivo with OATs or OATP substrates, suggesting the possibility of transporter-mediated drug-drug interactions. To avoid adverse consequences of such transporter-mediated drug-drug interactions, we need to be more aware of the role played by drug transporters as well as those caused by drug metabolizing enzymes.

Integrity signals

Registry

Crossref · 10.1146/annurev.pharmtox.44.101802.121444

Cites

199 of 199 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T. A., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,372
Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues.
Maliepaard, M., Scheffer, G. L., Faneyte, I. F., van Gastelen, M. A., Pijnenborg, A. C. L. M., Schinkel, A. H., van de Vijver, M. J., Scheper, R. J., & Schellens, J. H. M. (2001) · PubMed · Cited by 1,130
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
Schinkel, A. H., Mayer, U., Wagenaar, E., Mol, C. A. A. M., van Deemter, L., Smit, J. J. M., van der Valk, M. A., Voordouw, A. C., Spits, H., van Tellingen, O., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4028 · Cited by 937
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.
Miyake, K., Mickley, L. A., Litman, T., Zhan, Z., Robey, R. W., Cristensen, B., Brangi, M., Greenberger, L., Dean, M. C., Fojo, T., et al. (1999) · PubMed · Cited by 819
Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene
Paulusma, C. C., Bosma, P. J., Zaman, G. J. R., Bakker, C., Otter, M. Y., Scheffer, G. L., Scheper, R. J., Borst, P., & Elferink, R. P. J. O. (1996) · Science · doi:10.1126/science.271.5252.1126 · Cited by 817
A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.
Allikmets, R., Schriml, L. M., Hutchinson, A. A., Romano-Spica, V., & Dean, M. C. (1998) · PubMed · Cited by 798
Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance
Pang, K. S., & Rowland, M. (1977) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01059688 · Cited by 797
Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance
König, J., Nies, A. T., Cui, Y., Leier, I., & KEPPLER, D. O. R. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00169-8 · Cited by 786
Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K. E., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 718
Molecular and Functional Identification of Sodium Ion-dependent, High Affinity Human Carnitine Transporter OCTN2
Tamai, I., Ohashi, R., Nezu, J., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20378 · Cited by 696
Drug Resistance and ATP-Dependent Conjugate Transport Mediated by the Apical Multidrug Resistance Protein, MRP2, Permanently Expressed in Human and Canine Cells
Cui, Y., König, J., Buchholz, U., Spring, H., Leier, I., & KEPPLER, D. O. R. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23190-4 · Cited by 674
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., & Hori, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35757-0 · Cited by 672
The multidrug resistance protein family
Borst, P., Evers, R., Kool, M., & Wijnholds, J. (1999) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(99)00167-4 · Cited by 648
Molecular Identification and Characterization of Novel Members of the Human Organic Anion Transporter (OATP) Family
Tamai, I., Nezu, J., Uchino, H., Sai, Y., Oku, A., Shimane, M., & Tsuji, A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2922 · Cited by 643
cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats
Büchler, M. W., König, J., Brom, M., Kartenbeck, J., Spring, H., Horie, T., & KEPPLER, D. O. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.25.15091 · Cited by 639
Cloning and Characterization of Two Human Polyspecific Organic Cation Transporters
Gorboulev, V., Ulzheimer, J. C., Akhoundova, A., Ulzheimer-Teuber, I., Karbach, U., Quester, S., Baumann, C., Lang, F. J. W., Busch, A. E., & Koepsell, H. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.871 · Cited by 638
A Novel Human Hepatic Organic Anion Transporting Polypeptide (OATP2)
Hsiang, B. C., Zhu, Y., Wang, Z., Wu, Y., Sasseville, V. G., Yang, W.-P., & Kirchgessner, T. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37161 · Cited by 638
Clinical Pharmacokinetics of Atorvastatin
s, H. L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00005 · Cited by 636
Expression Cloning and Characterization of a Novel Multispecific Organic Anion Transporter
Sekine, T., Watanabe, N., Hosoyamada, M., Kanai, Y., & Endou, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18526 · Cited by 623
A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane
König, J., Cui, Y., Nies, A. T., & KEPPLER, D. O. R. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.1.g156 · Cited by 619
OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine
Cvetković, M., Leake, B. F., Fromm, M. F., Wilkinson, G. R., & Kim, R. B. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15235-x · Cited by 592
Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter
Nezu, J., Tamai, I., Oku, A., Ohashi, R., Yabuuchi, H., Hashimoto, N., Nikaido, H., Sai, Y., Koizumi, A., Shoji, Y., et al. (1999) · Nature Genetics · doi:10.1038/5030 · Cited by 553
Expression cloning of a rat liver Na(+)-independent organic anion transporter.
Jacquemin, E., Hagenbuch, B., Stieger, B., Wolkoff, A. W., & Meier, P. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.133 · Cited by 526
Localization and Genomic Organization of a New Hepatocellular Organic Anion Transporting Polypeptide
König, J., Cui, Y., Nies, A. T., & KEPPLER, D. O. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001448200 · Cited by 520
Prediction of Pharmacokinetic Alterations Caused by Drug-Drug Interactions: Metabolic Interaction in the Liver
Ito, K., Iwatsubo, T., Kanamitsu, S.-I., Ueda, K., Suzuki, H., & Sugiyama, Y. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01372-3 · Cited by 511
Self-citation
Identification and Characterization of Human Organic Anion Transporter 3 Expressing Predominantly in the Kidney
Ho, S., Sekine, T., Fukushima, J., Kanai, Y., Kobayashi, Y., Goya, T., & Endou, H. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1277 · Cited by 508
Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea.
Gupta, E., Lestingi, T. M., Mick, R., Ramirez, J., Vokes, E. E., & Ratain, M. J. (1994) · PubMed · Cited by 501
Mechanisms mediating renal secretion of organic anions and cations
Pritchard, J. B., & Miller, D. S. (1993) · Physiological Reviews · doi:10.1152/physrev.1993.73.4.765 · Cited by 495
Molecular Cloning and Characterization of a New Multispecific Organic Anion Transporter from Rat Brain
Kusuhara, H., Sekine, T., Utsunomiya‐Tate, N., Tsuda, M., Kojima, R., Ho, S., Sugiyama, Y., Kanai, Y., & Endou, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13675 · Cited by 488
Self-citation
A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation.
Taniguchi, K., WADA, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S.-I., & Kuwano, M. (1996) · PubMed · Cited by 470
Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1
Tamai, I., Yabuuchi, H., Nezu, J., Sai, Y., Oku, A., Shimane, M., & Tsuji, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01441-5 · Cited by 458
Cellular and molecular aspects of drug transport in the kidney
Inui, K., Masuda, S., & Saito, H. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00251.x · Cited by 450
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans
Hirano, M., Maeda, K., Shitara, Y., & Sugiyama, Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068056 · Cited by 444
Self-citation
Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2.
Hooijberg, J. H., Broxterman, H. J., Kool, M., Assaraf, Y. G., Peters, G. J., Noordhuis, P., Scheper, R. J., Borst, P., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 442
Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil
Shitara, Y., Hirano, M., Sato, H., & Sugiyama, Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068536 · Cited by 407
Self-citation
Molecular Cloning and Characterization of Multispecific Organic Anion Transporter 4 Expressed in the Placenta
Ho, S., Sekine, T., Kusuhara, H., Yu, E., Kim, J. Y., Kim, D. K., Sugiyama, Y., Kanai, Y., & Endou, H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4507 · Cited by 407
Self-citation
Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.
Ambudkar, S. V., Lelong-Rebel, I. H., Zhang, J., CARDARELLI, C. O., Gottesman, M. M., & PASTAN, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.18.8472 · Cited by 393
Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
Noé, B., Hagenbuch, B., Stieger, B., & Meier, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10346 · Cited by 392
Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
Elferink, R. P. J. O., Meijer, D. K. F., Kuipers, F., Jansen, P. L. M., Groen, A. K., & Groothuis, G. M. M. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00006-d · Cited by 386
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver
Vavricka, S. R., van Montfoort, J. E., Ha, H. R., Meier, P. J., & Fattinger, K. E. (2002) · Hepatology · doi:10.1053/jhep.2002.34133 · Cited by 373
Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver
Meier, P. J., Eckhardt, U., Schroeder, A., Hagenbuch, B., & Stieger, B. (1997) · Hepatology · doi:10.1002/hep.510260641 · Cited by 359
Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney
Hosoyamada, M., Sekine, T., Kanai, Y., & Endou, H. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.1.f122 · Cited by 359
Hereditary Chronic Conjugated Hyperbilirubinemia in Mutant Rats Caused by Defective Hepatic Anion Transport
Jansen, P. L. M., Peters, W. H. M., & Lamers, W. H. (1985) · Hepatology · doi:10.1002/hep.1840050408 · Cited by 347
LST-2, A human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers
Abe, T., Unno, M., Onogawa, T., Tokui, T., Kondo, T. N., Nakagomi, R., Adachi, H., Fujiwara, K., Okabe, M., Suzuki, T., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.24804 · Cited by 345
ABCG2 Transports Sulfated Conjugates of Steroids and Xenobiotics
Suzuki, M., Suzuki, H., Sugimoto, Y., & Sugiyama, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212399200 · Cited by 342
Self-citation
Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A
Shitara, Y., Itoh, T., Sato, H., Li, A. P., & Sugiyama, Y. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.041921 · Cited by 340
Self-citation
Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).
Tanigawara, Y., Okamura, N., Hirai, M., Yasuhara, M., Ueda, K., Kioka, N., Komano, T., & Hori, R. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10423-0 · Cited by 338
Gemfibrozil greatly increases plasma concentrations of cerivastatin
Backman, J. T. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.128469 · Cited by 337
Identification of multispecific organic anion transporter 2 expressed predominantly in the liver
Sekine, T., Ho, S., Tsuda, M., Apiwattanakul, N., Nakajima, N., Kanai, Y., & Endou, H. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00585-7 · Cited by 334
Human Neurons Express the Polyspecific Cation Transporter hOCT2, Which Translocates Monoamine Neurotransmitters, Amantadine, and Memantine
Busch, A. E., Karbach, U., Miska, D., Gorboulev, V., Akhoundova, A., Volk, C., Arndt, P., Ulzheimer, J. C., Sonders, M. S., Baumann, C., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.2.342 · Cited by 333
Functional Characteristics and Tissue Distribution Pattern of Organic Cation Transporter 2 (OCTN2), an Organic Cation/Carnitine Transporter
Wu, X., Huang, W. Y., Prasad, P. D., Seth, P., Rajan, D. P., Leibach, F. H., Chen, J., Conway, S. J., & Ganapathy, V. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35056-6 · Cited by 330
The multispecific organic anion transporter (OAT) family
Sekine, T., H, S., & Endou, H. (2000) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000297 · Cited by 324
Novel Membrane Transporter OCTN1 Mediates Multispecific, Bidirectional, and pH-Dependent Transport of Organic Cations
Yabuuchi, H., Tamai, I., Nezu, J.-I., Sakamoto, K., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38199-6 · Cited by 316
ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2
Jedlitschky, G., Leier, I., Buchholz, U., Hummel-Eisenbeiss, J., Burchell, B., & KEPPLER, D. O. R. (1997) · Biochemical Journal · doi:10.1042/bj3270305 · Cited by 302
Cryopreserved human hepatocytes: characterization of drug-metabolizing activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug–drug interaction potential
Li, A. P., Lu, C., Brent, J. A., Pham, C., Fackett, A., Ruegg, C. E., & Silber, P. M. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00088-5 · Cited by 302
Molecular aspects of hepatobiliary transport
Müller, M. M., & Jansen, P. L. M. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.6.g1285 · Cited by 302
The effect of gemfibrozil on the pharmacokinetics of rosuvastatin
Schneck, D. W. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.014 · Cited by 293
Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transporters
Dresser, M. J., Leabman, M. K., & Giacomini, K. M. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200104)90:4 · Cited by 289
Molecular cloning of canalicular multispecific organic anion transporter defective in EHBR
Ito, K., Suzuki, H., Hirohashi, T., Kume, K., Shimizu, T., & Sugiyama, Y. (1997) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1997.272.1.g16 · Cited by 288
Self-citation
QUANTITATIVE PREDICTION OF IN VIVO DRUG CLEARANCE AND DRUG INTERACTIONS FROM IN VITRO DATA ON METABOLISM, TOGETHER WITH BINDING AND TRANSPORT
Ito, K., Iwatsubo, T., Kanamitsu, S.-I., Nakajima, Y., & Sugiyama, Y. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.461 · Cited by 282
Self-citation
Human Organic Anion Transporters and Human Organic Cation Transporters Mediate Renal Antiviral Transport
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H. J., Kobayashi, Y., Yamamoto, T., Ho, S., Sekine, T., & Endou, H. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.918 · Cited by 276
Differential Recognition of β-Lactam Antibiotics by Intestinal and Renal Peptide Transporters, PEPT 1 and PEPT 2
Ganapathy, M. E., Brandsch, M., Prasad, P. D., Ganapathy, V., & Leibach, F. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25672 · Cited by 274
Na+-Dependent Carnitine Transport by Organic Cation Transporter (OCTN2): Its Pharmacological and Toxicological Relevance
Ohashi, R., Tamai, I., Yabuuchi, H., Nezu, J., Oku, A., Sai, Y., Shimane, M., & Tsuji, A. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35167-5 · Cited by 273
Characterization of Methotrexate Transport and Its Drug Interactions with Human Organic Anion Transporters
Takeda, M., Khamdang, S., Narikawa, S., Kimura, H. J., Hosoyamada, M., Ho, S., Sekine, T., & Endou, H. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034330 · Cited by 268
Plasma concentrations of active simvastatin acid are increased by gemfibrozil
Backman, J. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.108507 · Cited by 264
Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione
Paulusma, C. C., van Geer, M. A., Evers, R., Heijn, M., Ottenhoff, R., Borst, P., & Elferink, R. P. J. O. (1999) · Biochemical Journal · doi:10.1042/bj3380393 · Cited by 252
In Vitro Substrate Identification Studies for P-glycoprotein-Mediated Transport: Species Difference and Predictability of in Vivo Results
Yamazaki, M., Neway, W. E., Ohe, T., Chen, I., Rowe, J., Hochman, J. H., Chiba, M., & Lin, J. H. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38809-3 · Cited by 238
Transport of amphipathic anions by human multidrug resistance protein 3.
Zeng, H., Liu, G., Rea, P. A., & Kruh, G. D. (2000) · PubMed · Cited by 235
Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles. Evidence for an electrogenic canalicular organic anion carrier.
Meier, P. J., Meier-Abt, A. S., Barrett, C., & Boyer, J. L. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91006-9 · Cited by 228
Transcellular Transport of Organic Anions Across a Double-transfected Madin-Darby Canine Kidney II Cell Monolayer Expressing Both Human Organic Anion-transporting Polypeptide (OATP2/SLC21A6) and Multidrug Resistance-associated Protein 2 (MRP2/ABCC2)
Sasaki, M., Suzuki, H., Ito, K., Abe, T., & Sugiyama, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109081200 · Cited by 228
Self-citation
Human Liver-Specific Organic Anion Transporter, LST-1, Mediates Uptake of Pravastatin by Human Hepatocytes
Nakai, D., Nakagomi, R., Furuta, Y., Tokui, T., Abe, T., Ikeda, T., & Nishimura, K. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29609-9 · Cited by 217
Role of blood–brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain
Ohtsuki, S., Asaba, H., Takanaga, H., Deguchi, T., Hosoya, K., Otagiri, M., & Terasaki, T. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01108.x · Cited by 216
Are MDCK Cells Transfected with the Human MDR1 Gene a Good Model of the Human Intestinal Mucosa?
Tang, F., Horie, K., & Borchardt, R. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016140429238 · Cited by 213
Isolation of a Family of Organic Anion Transporters from Human Liver and Kidney
Sun, W. Y., Wu, R., van Poelje, P. D., & Erion, M. D. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4774 · Cited by 212
Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney
Shen, H., Smith, D. E., Yang, T., Huang, Y. G., Schnermann, J. B., & Brosius, F. C. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.5.f658 · Cited by 206
Vectorial Transport by Double-Transfected Cells Expressing the Human Uptake Transporter SLC21A8 and the Apical Export Pump ABCC2
Cui, Y., König, J., & KEPPLER, D. O. R. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.5.934 · Cited by 204
Cloning and Functional Characterization of a Novel Rat Organic Anion Transporter Mediating Basolateral Uptake of Methotrexate in the Kidney
Saito, H., Masuda, S., & Inui, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.34.20719 · Cited by 198
Comparative Studies on in Vitro Methods for Evaluating in Vivo Function of MDR1 P-Glycoprotein
Adachi, Y., Suzuki, H., & Sugiyama, Y. (2001) · Pharmaceutical Research · doi:10.1023/a:1013358126640 · Cited by 195
Self-citation
Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate
Kyrklund, C., Backman, J. T., Kivistö, K. T., Neuvonen, M., Laitila, J., & Neuvonen, P. J. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.115542 · Cited by 191
Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance
Kyrklund, C. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00052-3 · Cited by 189
Interaction of Human Organic Anion Transporters 2 and 4 with Organic Anion Transport Inhibitors
Enomoto, A., Takeda, M., Shimoda, M., Narikawa, S., Kobayashi, Y., Kobayashi, Y., Yamamoto, T., Sekine, T., Ho, S., Niwa, T., et al. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.797 · Cited by 187
BindingDB Entry 50042032: Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier.
BindingDB (2013) · PubMed · doi:10.7270/q2xw4m2t · Cited by 178
Effect of Multidrug Resistance-Reversing Agents on Transporting Activity of Human Canalicular Multispecific Organic Anion Transporter
Chen, Z., Kawabe, T., Ono, M., Aoki, S., Sumizawa, T., Furukawa, T., Uchiumi, T., Wada, M., Kuwano, M., & Akiyama, S.-I. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.6.1219 · Cited by 178
Role of transporters in the tissue-selective distribution and elimination of drugs: transporters in the liver, small intestine, brain and kidney
Kusuhara, H., & Sugiyama, Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00480-1 · Cited by 178
Self-citation
β-Lactam Antibiotics as Substrates for OCTN2, an Organic Cation/Carnitine Transporter
Ganapathy, M. E., Huang, W., Rajan, D. P., Carter, A. L., Sugawara, M., Iseki, K., Leibach, F. H., & Ganapathy, V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1699 · Cited by 175
Functional Characterization of an Organic Cation Transporter (hOCT1) in a Transiently Transfected Human Cell Line (HeLa)
Zhang, L., Schaner, M. E., & Giacomini, K. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37595-0 · Cited by 175
Molecular pharmacology of renal organic anion transporters
van Aubel, R. A. M. H., Masereeuw, R., & Rüssel, F. G. M. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.2.f216 · Cited by 170
Molecular Cloning and Characterization of Two Novel Human Renal Organic Anion Transporters (hOAT1 and hOAT3)
Race, J. E., Grassl, S. M., Williams, W. J., & Holtzman, E. J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9978 · Cited by 168
Cloning of the human kidney PAH transporter: narrow substrate specificity and regulation by protein kinase C
Lu, R., Chan, B. S., & Schuster, V. L. (1999) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1999.276.2.f295 · Cited by 168
Gender differences in expression of organic cation transporter OCT2 in rat kidney
Urakami, Y., Nakamura, N., Takahashi, K., Okuda, M., Saito, H., Hashimoto, Y., & Inui, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01491-x · Cited by 168
Excretion of GSSG and Glutathione Conjugates Mediated by MRP1 and CM0AT/MRP2
Suzuki, H., & Sugiyama, Y. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007170 · Cited by 163
Self-citation
Transport Properties of Nonsteroidal Anti-Inflammatory Drugs by Organic Anion Transporter 1 Expressed in Xenopus laevisOocytes
Apiwattanakul, N., Sekine, T., Chairoungdua, A., Kanai, Y., Nakajima, N., Sophasan, S., & Endou, H. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23181-3 · Cited by 158
Multispecific Organic Anion Transporter Is Responsible for the Biliary Excretion of the Camptothecin Derivative Irinotecan and its Metabolites in Rats
Chu, X., Kato, Y., Niinuma, K., Sudo, K.-I., Hakusui, H., & Sugiyama, Y. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36601-7 · Cited by 158
Self-citation
Increase in cerivastatin systemic exposure after single and multiple dosing in cyclosporine-treated kidney transplant recipients
Mueck, W., Mai, I., Fritsche, L., Ochmann, K., Rohde, G., Unger, S., Johne, A., Bauer, S., Budde, K., & Roots, I. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70104-9 · Cited by 158
Molecular Pharmacology of Organic Cation Transporters in Kidney
Koepsell, H., Gorboulev, V., & Arndt, P. (1999) · The Journal of Membrane Biology · doi:10.1007/s002329900475 · Cited by 155
The organic anion transporter family: from physiology to ontogeny and the clinic
Sweet, D. H., Bush, K. T., & Nigám, S. K. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.2.f197 · Cited by 155
Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
Bossuyt, X., Müller, M. M., Hagenbuch, B., & Meier, P. J. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12411-7 · Cited by 153
Role of human organic anion transporter 4 in the transport of ochratoxin A
Babu, E., Takeda, M., Narikawa, S., Kobayashi, Y., Enomoto, A., Tojo, A., Ho, S., Sekine, T., Sakthisekaran, D., & Endou, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00187-8 · Cited by 149
Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel
Li, A. P., Gorycki, P. D., Hengstler, J. G., Kedderis, G. L., Koebe, H. G., Rahmani, R., de Sousas, G., Silva, J. M., & Skett, P. (1999) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(99)00081-2 · Cited by 146
Expression and Functional Characterization of Rat Organic Anion Transporter 3 (rOat3) in the Choroid Plexus
Nagata, Y., Kusuhara, H., Endou, H., & Sugiyama, Y. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.5.982 · Cited by 144
Self-citation
Identification of organic anion transporting polypeptide 4 (Oatp4) as a major full‐length isoform of the liver‐specific transporter‐1 (rlst‐1) in rat liver
Cattori, V., Hagenbuch, B., Hagenbuch, N., Stieger, B., Ha, R., Winterhalter, K. H., & Meier, P. J. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01596-9 · Cited by 144
Preclinical evaluation of drug—drug interaction potential: present status of the application of primary human hepatocytes in the evaluation of cytochrome P450 induction
Li, A. P., Maurel, P., Gómez-Lechón, M. J., Cheng, L. C., & Jurima‐Romet, M. (1997) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(97)00070-7 · Cited by 144
Relationship between Development of Diarrhea and the Concentration of SN‐38, an Active Metabolite of CPT‐11, in the Intestine and the Blood Plasma of Athymic Mice Following Intraperitoneal Administration of CPT‐11
Araki, E., Ishikawa, M., Iigo, M., Koide, T., Itabashi, M., & Hoshi, A. (1993) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1993.tb02031.x · Cited by 142
Functional Involvement of Rat Organic Anion Transporter 3 (rOat3;Slc22a8) in the Renal Uptake of Organic Anions
Hasegawa, M., Kusuhara, H., Sugiyama, D., Ito, K., Ueda, S., Endou, H., & Sugiyama, Y. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.746 · Cited by 141
Self-citation
Recent Advances in Carrier-mediated Hepatic Uptake and Biliary Excretion of Xenobiotics
Yamazaki, M., Suzuki, H., & Sugiyama, Y. (1996) · Pharmaceutical Research · doi:10.1023/a:1016077517241 · Cited by 138
Self-citation
Plasma Concentration Profiles of Simvastatin 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitory Activity in Kidney Transplant Recipients with and without Ciclosporin
Árnadóttir, M., Eriksson, L.-O., Thysell, H., & Karkas, J. D. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187521 · Cited by 137
The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis
Tracy, T. S., Krohn, K., Jones, D. R., Bradley, J. D., Hall, S. D., & Brater, D. C. (1992) · European Journal of Clinical Pharmacology · doi:10.1007/bf00278469 · Cited by 134
Dehydroepiandrosterone sulfate (DHEAS): identification of a carrier protein in human liver and brain
Kullak-Ublick, G. A., Fisch, T., Oswald, M., Hagenbuch, B., Meier, P. J., Beuers, U. H., & Paumgartner, G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00168-9 · Cited by 133
Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus
Ichimaru, N. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00438-5 · Cited by 128
Cloning and Expression of Murine Sister of P-Glycoprotein Reveals a More Discriminating Transporter ThanMDR1/P-Glycoprotein
Lecureur, V., Sun, D., Hargrove, P., Schuetz, E. G., Kim, R. B., Lan, L.-B., & Schuetz, J. D. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26438-5 · Cited by 128
Cloning and Functional Characterization of a New Multispecific Organic Anion Transporter, OAT-K2, in Rat Kidney
Masuda, S., Ibaramoto, K., Takeuchi, A., Saito, H., Hashimoto, Y., & Inui, K. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23037-6 · Cited by 127
Bilateral Pharmacokinetic Interaction Between Cyclosporine A and Atorvastatin in Renal Transplant Recipients
Åsberg, A., Hartmann, A., Fjeldså, E., Bergan, S., & Holdaas, H. (2001) · American Journal of Transplantation · doi:10.1034/j.1600-6143.2001.10415.x · Cited by 127
BindingDB Entry 50040211: The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
BindingDB (2013) · PubMed · doi:10.7270/q2h41sjq · Cited by 126
Transport Activity of Human MRP3 Expressed in Sf9 Cells: Comparative Studies with Rat MRP3
Akita, H., Suzuki, H., Hirohashi, T., Takikawa, H., & Sugiyama, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1013699130991 · Cited by 125
Self-citation
Clinical Pharmacokinetics of Cerivastatin
ck, W. M. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200039020-00002 · Cited by 122
Effect of antisense oligonucleotides on the expression of hepatocellular bile acid and organic anion uptake systems in Xenopus laevis oocytes
Hagenbuch, B., Scharschmidt, B. F., & Meier, P. J. (1996) · Biochemical Journal · doi:10.1042/bj3160901 · Cited by 122
Interaction of human organic anion transporters with various cephalosporin antibiotics
Takeda, M., Babu, E., Narikawa, S., & Endou, H. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01306-7 · Cited by 121
Methotrexate and Nonsteroidal Antiinflammatory Drug Interactions
Frenia, M. L., Long, K. S., & Hartshorn, E. A. (1992) · Annals of Pharmacotherapy · doi:10.1177/106002809202600219 · Cited by 118
The Role of P-Glycoprotein and Canalicular Multispecific Organic Anion Transporter in the Hepatobiliary Excretion of Drugs
Kusuhara, H., Suzuki, H., & Sugiyama, Y. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970100b · Cited by 117
Self-citation
Function of Uptake Transporters for Taurocholate and Estradiol 17β-D-Glucuronide in Cryopreserved Human Hepatocytes
Shitara, Y., Li, A. P., Kato, Y., Lu, C., Ito, K., Itoh, T., & Sugiyama, Y. (2003) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.18.33 · Cited by 116
Self-citation
Characterization of ochratoxin A transport by human organic anion transporters
Jung, K. Y., Takeda, M., Kim, D. K., Tojo, A., Narikawa, S., Yoo, B. S., Hosoyamada, M., Ho, S., Sekine, T., & Endou, H. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01296-6 · Cited by 114
Interaction and Transport of Thiazide Diuretics, Loop Diuretics, and Acetazolamide via Rat Renal Organic Anion Transporter rOAT1
Uwai, Y., Saito, H., Hashimoto, Y., & Inui, K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38896-2 · Cited by 114
Altered disposition of pravastatin following concomitant drug therapy with cyclosporin A in transplant recipients.
Regazzi, M. B., Iacona, I., Campana, C., Raddato, V., Lesi, C., Perani, G., Gavazzi, A., & Viganò, M. (1993) · PubMed · Cited by 114
cDNA Cloning, Functional Characterization, and Tissue Distribution of an Alternatively Spliced Variant of Organic Cation Transporter hOCT2 Predominantly Expressed in the Human Kidney
Urakami, Y., Akazawa, M., Saito, H., Okuda, M., & Inui, K. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019413.78751.46 · Cited by 113
Characterization of organic anion transport inhibitors using cells stably expressing human organic anion transporters
Takeda, M., Narikawa, S., Hosoyamada, M., Ho, S., Sekine, T., & Endou, H. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00962-1 · Cited by 111
Comparative Inhibitory Effects of Different Compounds on Rat Oatp1 (Slc21a1)- and Oatp2 (Slc21a5)-Mediated Transport
Shitara, Y., Sugiyama, D., Kusuhara, H., Kato, Y., Abe, T., Meier, P. J., Itoh, T., & Sugiyama, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1014264614637 · Cited by 107
Self-citation
Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells
Versantvoort, C. H. M., Broxterman, H. J., Lankelma, J., Feller, N., & Pinedo, H. M. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90149-x · Cited by 106
Pharmacokinetics of the combination of fluvastatin and gemfibrozil
Spence, J. D., Muñoz, C. E., Hendricks, L., Latchinian, L., & Khouri, H. E. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80024-4 · Cited by 102
The Potential for an Interaction between MRP2 (ABCC2) and Various Therapeutic Agents: Probenecid as a Candidate Inhibitor of the Biliary Excretion of Irinotecan Metabolites
Horikawa, M., Kato, Y., Tyson, C. A., & Sugiyama, Y. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.23 · Cited by 101
Self-citation
Human Organic Anion Transporters Mediate the Transport of Tetracycline
Babu, E., Takeda, M., Narikawa, S., Kobayashi, Y., Yamamoto, T., Ho, S., Sekine, T., Sakthisekaran, D., & Endou, H. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.88.69 · Cited by 100
The Predominant Contribution of Oligopeptide Transporter PepT1 to Intestinal Absorption of β-Lactam Antibiotics in the Rat Small Intestine
Tamai, I., Nakanishi, T., Hayashi, K., Terao, T., Sai, Y., Shiraga, T., Miyamoto, K., Takeda, E., Higashida, H., & Tsuji, A. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06115.x · Cited by 95
Transporter-mediated Drug Interactions
Tsuji, A. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.253 · Cited by 94
Functional Characterization of Rat Organic Anion Transporter 2 in LLC-PK1 Cells
Morita, N., Kusuhara, H., Sekine, T., Endou, H., & Sugiyama, Y. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29490-8 · Cited by 93
Self-citation
Transport of Drugs Across the Hepatic Sinusoidal Membrane: Sinusoidal Drug Influx and Efflux in the Liver
Suzuki, H. I., & Sugiyama, Y. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-8408 · Cited by 92
Self-citation
The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
Jm, K., & Ra, H. (1995) · PubMed · Cited by 92
Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2
Fattinger, K. E., Cattori, V., Hagenbuch, B., Meier, P. J., & Stieger, B. (2000) · Hepatology · doi:10.1053/jhep.2000.8539 · Cited by 91
Are MDCK Cells Transfected with the Human MRP2 Gene a Good Model of the Human Intestinal Mucosa?
Tang, F., Horie, K., & Borchardt, R. T. (2002) · Pharmaceutical Research · doi:10.1023/a:1016192413308 · Cited by 91
Taxol transport by human intestinal epithelial Caco-2 cells.
Walle, U. K., & Walle, T. (1998) · PubMed · Cited by 87
Delineating the Contribution of Secretory Transporters in the Efflux of Etoposide Using Madin-Darby Canine Kidney (MDCK) Cells Overexpressing P-Glycoprotein (Pgp), Multidrug Resistance-Associated Protein (MRP1), and Canalicular Multispecific Organic Anion Transporter (cMOAT)
Guo, A., Marinaro, W., Hu, P., & Sinko, P. J. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.4.457 · Cited by 86
Tubular Localization and Tissue Distribution of Peptide Transporters in Rat Kidney
Smith, D. E., Pavlova, A. V., Berger, U. V., Hediger, M. A., Yang, T., Huang, Y. G., & Schnermann, J. B. (1998) · Pharmaceutical Research · doi:10.1023/a:1011996009332 · Cited by 86
EVALUATION OF FLUVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN RENAL TRANSPLANT RECIPIENTS TAKING CYCLOSPORINE1
Goldberg, R., & Roth, D. (1996) · Transplantation · doi:10.1097/00007890-199612150-00005 · Cited by 85
Kinetics of metabolite formation and elimination in the perfused rat liver preparation: differences between the elimination of preformed acetaminophen and acetaminophen formed from phenacetin.
Pang, K. S., & Gillette, J. R. (1978) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)31406-0 · Cited by 85
Effect of Cryopreservation on Cytochrome P-450 Enzyme Induction in Cultured Rat Hepatocytes
Madan, A., DeHaan, R. D., Mudra, D., Carroll, K., LeCluyse, E. L., & Parkinson, A. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14907-0 · Cited by 85
Identification of Basic Residues Involved in Drug Export Function of Human Multidrug Resistance-associated Protein 2
Ryu, S., Kawabe, T., Nada, S., & Yamaguchi, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005149200 · Cited by 82
Interaction between methotrexate and nonsteroidal anti-inflammatory drugs in organic anion transporter
Uwai, Y., Saito, H., & Inui, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00837-2 · Cited by 79
Pravastatin, an HMG-CoA Reductase Inhibitor, Is Transported by Rat Organic Anion Transporting Polypeptide, oatp2
Tokui, T., Nakai, D., Nakagomi, R., Yawo, H., Abe, T., & Sugiyama, Y. (1999) · Pharmaceutical Research · doi:10.1023/a:1018838405987 · Cited by 79
Self-citation
Multidrug resistance-associated protein subfamily transporters and drug resistance.
Kuwano, M., Toh, S., Uchiumi, T., Takano, H., Kohno, K., & Wada, M. (1999) · PubMed · Cited by 79
Contribution of Sodium Taurocholate Co-Transporting Polypeptide to the Uptake of Its Possible Substrates Into Rat Hepatocytes
Kouzuki, H., Suzuki, H., Ito, K., Ohashi, R., & Sugiyama, Y. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37686-4 · Cited by 78
Self-citation
A new rat mutant with chronic conjugated hyperbilirubinemia and renal glomerular lesions.
Hosokawa, S., Tagaya, O., Mikami, T., Nozaki, Y., Kawaguchi, A., Yamatsu, K., & Shamoto, M. (1992) · PubMed · Cited by 77
Quantitative Evaluation of the Drug-Drug Interactions between Methotrexate and Nonsteroidal Anti-Inflammatory Drugs in the Renal Uptake Process Based on the Contribution of Organic Anion Transporters and Reduced Folate Carrier
Nozaki, Y., Kusuhara, H., Endou, H., & Sugiyama, Y. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061812 · Cited by 76
Self-citation
Drug Transporters: Their Role and Importance in the Selection and Development of New Drugs
Mizuno, N., & Sugiyama, Y. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.93 · Cited by 75
Self-citation
The organic cation transporter OCT2 mediates the uptake of β‐adrenoceptor antagonists across the apical membrane of renal LLC‐PK1 cell monolayers
Dudley, A. J., Bleasby, K., & Brown, C. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703518 · Cited by 74
[34] Preparation of basolateral (sinusoidal) and canalicular plasma membrane vesicles for the study of hepatic transport processes
Meier, P. J., & Boyer, J. L. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)92092-r · Cited by 74
Practical Clinical Pharmacology and Drug Interactions of Low-Dose Methotrexate Therapy in Rheumatoid Arthritis
Fürst, D. E. (1995) · Lara D. Veeken · doi:10.1093/rheumatology/xxxiv.suppl_2.20 · Cited by 74
Interactions in the renal and biliary elimination of digoxin: Stereoselective difference between quinine and quinidine
Hedman, A., Angelin, B., Arvidsson, A., Dahlqvist, R., & Nilsson, B. (1990) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1990.3 · Cited by 74
Regulation of renal oatp mRNA expression by testosterone
Lu, R., KANAI, N., Bao, Y., Wolkoff, A. W., & Schuster, V. L. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.2.f332 · Cited by 74
Reduced Gastrointestinal Toxicity Following Inhibition of the Biliary Excretion of Irinotecan and Its Metabolites by Probenecid in Rats
Horikawa, M., Kato, Y., & Sugiyama, Y. (2002) · Pharmaceutical Research · doi:10.1023/a:1020358910490 · Cited by 71
Self-citation
The Modified Dipeptide, Enalapril, An Angiotensin–Converting Enzyme Inhibitor, Is Transported by the Rat Liver Organic Anion Transport Protein
Pang, K. S., Wang, P. J., Chung, A. Y., & Wolkoff, A. W. (1998) · Hepatology · doi:10.1002/hep.510280524 · Cited by 69
Transport of Temocaprilat into Rat Hepatocytes: Role of Organic Anion Transporting Polypeptide
Ishizuka, H., Konno, K., Naganuma, H., Nishimura, K., Kouzuki, H., Suzuki, H., Stieger, B., Meier, P. J., & Sugiyama, Y. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37760-2 · Cited by 67
Self-citation
The applicability of rat and human liver slices to the study of mechanisms of hepatic drug uptake
Olinga, P., Hof, I. H., Merema, M. T., Smit, M., de Jager, M. H., Swart, P. J., Slooff, M. J. H., Meijer, D. K. F., & Groothuis, G. M. M. (2001) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(01)00127-7 · Cited by 64
Transport of organic anions in the liver. An update on bile acid, fatty acid, monocarboxylate, anionic amino acid, cholephilic organic anion, and anionic drug transport
Petzinger, E. (1994) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/bfb0030903 · Cited by 63
Cephalosporin-Probenecid Drug Interactions
Brown, G. R. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324040-00003 · Cited by 60
Primary active transport of organic anions on bile canalicular membrane in humans
Niinuma, K., Kato, Y., Suzuki, H., Tyson, C. A., Weizer, V., Dabbs, J. E., Froehlich, R., Green, C. E., & Sugiyama, Y. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.5.g1153 · Cited by 60
Self-citation
Involvement of rat organic anion transporter 3 (rOAT3) in cephaloridine-induced nephrotoxicity: In comparison with rOAT1
Jung, K. Y., Takeda, M., Shimoda, M., Narikawa, S., Tojo, A., Kim, D. K., Chairoungdua, A., Choi, B. K., Kusuhara, H., Sugiyama, Y., et al. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01500-x · Cited by 59
Self-citation
Inhibition of Biliary Excretion of Methotrexate by Probenecid in Rats: Quantitative Prediction of Interaction from in Vitro Data
Ueda, K., Kato, Y., Komatsu, K., & Sugiyama, Y. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29630-0 · Cited by 58
Self-citation
ATP-dependent export pumps and their inhibition by cyclosporins
Böhme, M., Jedlitschky, G., Leier, I., Büchler, M. W., & KEPPLER, D. O. R. (1994) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(94)90023-x · Cited by 57
Bile acid and xenobiotic transporters in liver
Stieger, B., & Meier, P. J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80059-8 · Cited by 56
Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method
Miyauchi, S., Sugiyama, Y., Sawada, Y., Morita, K., Iga, T., & Hanano, M. (1987) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf01062937 · Cited by 54
Self-citation
Interactions of Nonsteroidal Anti-inflammatory Drugs with Rat Renal Organic Anion Transporter, OAT-K1
Masuda, S., Saito, H., & Inui, K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37172-1 · Cited by 51
Contribution of Organic Anion Transporting Polypeptide to Uptake of Its Possible Substrates into Rat Hepatocytes
Kouzuki, H., Suzuki, H., Ito, K., Ohashi, R., & Sugiyama, Y. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37999-6 · Cited by 50
Self-citation
TISSUE-SELECTIVE UPTAKE OF PRAVASTATIN IN RATS: CONTRIBUTION OF A SPECIFIC CARRIER-MEDIATED UPTAKE SYSTEM
Yamazaki, M., Tokui, T., Ishigami, M., & Sugiyama, Y. (1996) · Biopharmaceutics & Drug Disposition · doi:10.1002/(sici)1099-081x(199612)17:9 · Cited by 47
Self-citation
Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates
Sugiyama, D., Kusuhara, H., Shitara, Y., Abe, T., & Sugiyama, Y. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.220 · Cited by 46
Self-citation
Functional expression of novel peptide transporter in renal basolateral membranes
Terada, T., Sawada, K., Ito, T., Saito, H., Hashimoto, Y., & Inui, K. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.5.f851 · Cited by 44
Evaluation of the uptake of pravastatin by perfused rat liver and primary cultured rat hepatocytes.
Ishigami, M., Tokui, T., KOMAI, T., Tsukahara, K., Yamazaki, M., & Sugiyama, Y. (1995) · Pharmaceutical Research · doi:10.1023/a:1016226024587 · Cited by 43
Self-citation
Multispecific Substrate Recognition of Kidney-Specific Organic Anion Transporters OAT-K1 and OAT-K2
Takeuchi, A., Masuda, S., Saito, H., Abe, T., & Inui, K. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29326-5 · Cited by 42
CHO/hPEPT1 cells overexpressing the human peptide transporter (hPEPT1) as an alternative in vitro model for peptidomimetic drugs
Han, H.-K., Rhie, J. K., Oh, D.-M., Saito, G., Hsu, C.-P., Stewart, B. H., & Amidon, G. L. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980132e · Cited by 42
Functional analysis of rat renal organic anion transporter OAT‐K1: bidirectional methotrexate transport in apical membrane
Masuda, S., Takeuchi, A., Saito, H., Hashimoto, Y., & Inui, K. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01221-1 · Cited by 41
Exaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders
Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F. (2001) · Annals of Pharmacotherapy · doi:10.1345/aph.1a031 · Cited by 40
Effect of probenecid on the elimination and protein binding of ceftriaxone
Stoeckel, K., Trueb, V., Dubach, U. C., & McNamara, P. J. (1988) · European Journal of Clinical Pharmacology · doi:10.1007/bf00614552 · Cited by 39
Disposition of gemfibrozil and gemfibrozil acyl glucuronide in the rat isolated perfused liver.
Sallustio, B. C., Fairchild, B. A., Shanahan, K. M., Evans, A. M., & Nation, R. L. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07493-8 · Cited by 35
Exercise Training and Bleed Viscosity in Patients With Ischemic Heart Disease
Levine, G. N., O’Malley, C. J., & Balady, G. J. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80808-x · Cited by 34
[33] Characterizing mechanisms of hepatic bile acid transport utilizing isolated membrane vesicles
Boyer, J. L., & Meier, P. J. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)92091-q · Cited by 34
An open-label study on the pharmacokinetics (PK) of pitavastatin (NK-104) when administered concomitantly with fenofibrate or gemfibrozil in healthy volunteers
Mathew, P. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.11.125 · Cited by 32
Effect of Probenecid on the Blood Levels and Urinary Excretion of Cefamandole
Griffith, R. S., Black, H. R., Brier, G. L., & Wolny, J. D. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.809 · Cited by 31
Hepatic disposition of the acyl glucuronide1-O-gemfibrozil-beta-D-glucuronide: effects of dibromosulfophthalein on membrane transport and aglycone formation.
Sabordo, L., Sallustio, B. C., Evans, A. M., & Nation, R. L. (1999) · PubMed · Cited by 29
The interaction of cephalosporin antibiotics with renal cortex of rats: Accumulation to cortical slices and binding to purified plasma membranes
Hori, R., ISHIKAWA, Y., Takano, M., Okano, T., KITAZAWA, S., & Inui, K.-I. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90113-7 · Cited by 28
Characterization of the Uptake of Rocuronium and Digoxin in Human Hepatocytes: Carrier Specificity and Comparison with in Vivo Data
Olinga, P., Merema, M. T., Hof, I. H., Slooff, M. J. H., Proost, J. H., Meijer, D. K. F., & Groothuis, G. M. M. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37452-x · Cited by 27
Rat Renal Organic Anion Transporter rOAT1 Mediates Transport of Urinary-Excreted Cephalosporins, but not of Biliary-Excreted Cefoperazone
Uwai, Y., Saito, H., & Inui, K. (2002) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.17.125 · Cited by 25
Inhibitory effect of anti-diabetic agents on rat organic anion transporter rOAT1
Uwai, Y., Saito, H., Hashimoto, Y., & Inui, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00324-1 · Cited by 21
Drug Concentration Monitoring
Brown, G. R., Miyata, M., & McCormack, J. P. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199324030-00001 · Cited by 19
Hepatic disposition of the acyl glucuronide 1-O-gemfibrozil-beta-D-glucuronide: effects of clofibric acid, acetaminophen, and acetaminophen glucuronide.
Sabordo, L., Sallustio, B. C., Evans, A. M., & Nation, R. L. (2000) · PubMed · Cited by 18
[20] Transport studies with renal proximal tubular and small intestinal brush border and basolateral membrane vesicles: Vesicle heterogeneity, coexistence of transport systems
Murer, H., Gmaj, P., Stieger, B., & Hagenbuch, B. (1989) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(89)72023-1 · Cited by 17
[26] Isolation of lumenal and contralumenal plasma membrane vesicles from kidney
Kinne-Saffran, E., & Kinne, R. K.-H. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)91029-6 · Cited by 16
Stereoselective Inhibition by the Diastereomers Quinidine and Quinine of Uptake of Cardiac Glycosides into Isolated Rat Hepatocytes
Hedman, A., & Meijer, D. K. F. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970334v · Cited by 13
Carrier-Mediated Hepatic Uptake of Peptidic Endothelin Antagonists in Rats
Akhteruzzaman, S., Kato, Y., Kouzuki, H., Suzuki, H., Hisaka, A., Stieger, B., Meier, P. J., & Sugiyama, Y. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35012-8 · Cited by 11
Self-citation
The pharmacokinetics of cefadroxil associated with probenecid.
Mariño, E. L., & Domínguez‐Gil, A. (1981) · PubMed · Cited by 11
Viability of Liver Slices Exhibiting Absorption, Metabolism, and Elimination of Substrates in Culture Medium
SHIGEMATSU, A., MOTOJI, N., Momose, Y., Iida, A., & Higashi, N. (2000) · Experimental and Molecular Pathology · doi:10.1006/exmp.2000.2325 · Cited by 10
Renal transport of drugs: an overview of methodology with application to cimetidine.
Giacomini, K. M., Hsyu, P., & Gisclon, L. G. (1988) · Pharmaceutical Research · doi:10.1023/a:1015904905235 · Cited by 8
Use of an Isolated Perfused Kidney to Assess Renal Clearance of Drugs
Okudaira, N., & Sugiyama, Y. (1996) · Pharmaceutical biotechnology · doi:10.1007/978-1-4899-1863-5_12 · Cited by 5
Self-citation

Research works printed but not linked: 52

Pang KS, 1978, J. Pharmacol. Exp. Ther., 207, 178
Lecureur V, 2000, Mol. Pharmacol., 57, 24
Yamazaki M, 2001, J. Pharmacol. Exp. Ther., 296, 723
Walle UK, 1998, Drug Metab. Dispos., 26, 343
Tanigawara Y, 1992, J. Pharmacol. Exp. Ther., 263, 840
Zhang L, 1998, J. Pharmacol. Exp. Ther., 286, 354
Yabuuchi H, 1999, J. Pharmacol. Exp. Ther., 289, 768
Wu X, 1999, J. Pharmacol. Exp. Ther., 290, 1482
Ohashi R, 1999, J. Pharmacol. Exp. Ther., 291, 778
Nakai D, 2001, J. Pharmacol. Exp. Ther., 297, 861
Ishizuka H, 1998, J. Pharmacol. Exp. Ther., 287, 37
Hosokawa S, 1992, Lab. Animal Sci., 42, 27
Muller M, 1997, Am. J. Physiol., 272, G1285
10.1016/0304-4157(95)00006-D · DOI
Taniguchi K, Cancer Res., 56, 4124
Kuwano M, 1999, Anticancer Drug Des., 14, 123
Niinuma K, 1999, Am. J. Physiol, 276, G1153
Cui Y, 1999, Mol. Pharmacol., 55, 929
Niinuma K, 1999, Am. J. Physiol, 276, G1153
Hooijberg JH, 1999, Cancer Res., 59, 2532
Zeng H, 2000, Cancer Res., 60, 4779
Allikmets R, 1998, Cancer Res., 58, 5337
Miyake K, 1999, Cancer Res., 59, 8
Maliepaard M, 2001, Cancer Res., 61, 3458
Akhteruzzaman S, 1999, J. Pharmacol. Exp. Ther., 290, 1107
Madan A, 1999, Drug Metab. Dispos., 27, 327
Kouzuki H, 1998, J. Pharmacol. Exp. Ther., 286, 1043
Kouzuki H, 1999, J. Pharmacol. Exp. Ther, 288, 627
Ito K, 1998, Pharmacol. Rev., 50, 387
Ueda K, 2001, J. Pharmacol. Exp. Ther., 297, 1036
Masuda S, 1997, J. Pharmacol. Exp. Ther., 283, 1039
Masuda S, 1999, Mol. Pharmacol., 55, 743
Takeuchi A, 2001, J. Pharmacol. Exp. Ther., 299, 261
Chu XY, 1997, J. Pharmacol. Exp. Ther., 281, 304
Gupta E, 1994, Cancer Res., 54, 3723
Regazzi MB, 1993, Transplant. Proc., 25, 2732
Hasunuma T, 2003, J. Clin. Ther. Med., 19, 381
10.1345/aph.1A116 · DOI
Mueck W, 2001, AAPS PharmSci., 3, 3566
Sallustio BC, 1996, Drug Metab. Dispos., 24, 984
Sabordo L, 1998, J. Pharmacol. Exp. Ther., 288, 414
Sabordo L, 2000, J. Pharmacol. Exp. Ther., 295, 44
Olinga P, 1998, J. Pharmacol. Exp. Ther., 285, 506
Marino EL, 1981, Int. J. Clin. Pharmacol. Ther. Toxicol., 19, 506
Kremer JM, 1995, J. Rheumatol., 22, 2072
Apiwattanakul N, 1999, Mol. Pharmacol., 55, 847
Morita N, 2001, J. Pharmacol. Exp. Ther., 298, 1179
Jariyawat S, 1999, J. Pharmacol. Exp. Ther, 290, 672
Uwai Y, 2000, J. Pharmacol. Exp. Ther., 295, 261
Cvetkovic M, 1999, Drug Metab. Dispos., 27, 866
Bossuyt X, 1996, J. Pharmacol. Exp. Ther., 276, 891–96
Sugiyama D, 2001, J. Pharmacol. Exp. Ther., 298, 316–22

Sorted by citations

Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Self-citation
Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
Self-citation
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
Neuvonen, P. J., Niemi, M., & Backman, J. T. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2006.09.003 · Cited by 874
Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Coexistence of passive and carrier-mediated processes in drug transport
Sugano, K., Kansy, M., Artursson, P., Avdeef, A., Bendels, S., Di, L., Ecker, G. F., Faller, B., Fischer, H., Gerebtzoff, G., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3187 · Cited by 672

See all 337

Authors: Shitara, Y., Sato, H., & Sugiyama, Y.
Affiliations: SHOWA Medical University (JP)
The University of Tokyo (JP)
ORCID: Sato, Hitoshi
Sugiyama, Yuichi
Venue: Annual Review of Pharmacology and Toxicology
Publisher: Annual Reviews
Published: 2005-09-22
Volume: 45
Issue: 1
Pages: 689-723
ISSN: 0362-1642 (ISSN-L)
1545-4304
DOI: 10.1146/annurev.pharmtox.44.101802.121444
OpenAlex: W2066382275
Cited by: 336
References: 199
Citations by year: 2026: 2 · 2025: 3 · 2024: 4 · 2023: 5 · 2022: 5 · 2021: 11 · 2020: 8 · 2019: 7 · 2018: 9 · 2017: 14 · 2016: 15 · 2015: 12 · 2014: 14 · 2013: 23 · 2012: 25
FWCI: 2.12
Type: journal article
Language: en
Open access: closed
Locations: The Annual Review of Pharmacology and Toxicology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
Keywords: drug-drug interactions, drug transporters, renal drug excretion, organic anion transporting polypeptides, organic anion transporters, transporter inhibitors, Ki values, substrate specificity, probenecid, cephalosporins, cyclosporine, rifampicin, drug-metabolizing enzymes
MeSH terms: Animals, Biliary Tract, Biological Transport, Drug Evaluation, Drug Interactions, Pharmaceutical Preparations, Humans, Kidney, Liver

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

EVALUATION OF DRUG-DRUG INTERACTION IN THE HEPATOBILIARY AND RENAL TRANSPORT OF DRUGS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks